lung cancer | |||||
新闻 | |||||
Taiwan approves Ono Pharma's non-small cell lung cancer drug with chemotherapy Opdivo intravenous infusion approved for neoadjuvant treatment of resectable non-small cell lung cancer in combination with chemotherapy in ...
| |||||
Lung Cancer Surgery Market worth $6.7 billion by 2026 – Exclusive Report by MarketsandMarkets™ Based on procedures, the lung cancer surgery market is segmented into thoracotomy and minimally invasive surgeries. In 2020, the thoracotomy segment ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment